For patients with chronic lymphocytic leukemia (CLL) treated previously with venetoclax and Bruton’s tyrosine kinase ...

The FDA has approved updated drug labeling for Sandoz in the treatment of B-cell chronic lymphocytic leukemia.

GEO-CM04S1 Improved Immune Response vs mRNA VaccineATLANTA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology ...

Despite the emergence of more effective treatments, mainly the combination of immunotherapy with fludarabine-based regimens, CLL remains incurable. These more intensive therapies achieve the ...

Treatment of elderly with CLL is today ... in a majority of patients with relapsed or refractory chronic lymphocytic leukemia (CLL). The safety profile results reveal a relatively low incidence ...

To see if you have chronic lymphocytic leukemia, your doctor will run some tests on your blood, bone marrow, and lymph nodes. If your CLL is in the early stages, you may not need treatment right away.

Nurix Therapeutics (NRIX) announced that the European Medicines Agency, or EMA, has granted PRIME designation for NX-5948, a highly selective ...

Ascentage Pharma (6855.HK) is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in ...

The FDA updated the fludarabine phosphate injection labeling under Project Renewal, clarifying the dosage for combination ...

Jim Plotkin's year began just like any other back in 2018. The former touring golf professional and teaching professional at ...

Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting ...